Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis

  1. Michael Benatar
  2. Eric A. Macklin
  3. Andrea Malaspina
  4. Mary-Louise Rogers
  5. Eran Hornstein
  6. Vittoria Lombardi
  7. Danielle Renfrey
  8. Stephanie Shepheard
  9. Iddo Magen
  10. Yahel Cohen
  11. Volkan Granit
  12. Jeffrey M. Statland
  13. Jeannine M. Heckmann
  14. Rosa Rademakers
  15. Caroline A. McHutchison
  16. Leonard Petrucelli
  17. Corey T. McMillan
  18. Joanne Wuu
  19. Michael Benatar
  20. Volkan Granit
  21. Jeffrey M. Statland
  22. Jeannine M. Heckmann
  23. Corey T. McMillan
  24. Lauren Elman
  25. John Ravits
  26. Jonathan Katz
  27. Jaya Trivedi
  28. Andrea Swenson
  29. Ted M. Burns
  30. James Caress
  31. Carlayne Jackson
  32. Samuel Maiser
  33. Erik P. Pioro
  34. Yuen So
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.ebiom.2024.105323
  2. Version published to 10.1101/2024.08.12.24311876 on medRxiv